The Latest Breaking News from GoodRx

The most significant Medicare change for 2025 will be the new $2,000 cap for prescription drugs.

GoodRx's latest research shows surging demand for weight loss medications like Wegovy and Zepbound, despite high costs and limited insurance coverage, with consumers overspending $200 million in 2024.

Flovent — a common asthma inhaler — will be discontinued in 2024. There will be a generic version available, but the change could make it hard for some patients to get their medication.

Walgreens says its Rx Savings Finder will help customers compare coupon prices to get the best deal.

GoodRx’s prescription savings program offers significant discounts on prescription drugs, but not without some catches

These outperformers are all trading under $10 per share - for now. After beating the S&P 500 year-to-date, analysts think these standout single-digit stocks all have room to keep running higher.

The agency says the fertility app Premom deceived users about their data.

The billionaire entrepreneur is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.

Since 2017, GoodRx has helped millions of people find deals on prescription drugs via an app and website. But what its customers may not have known is that the Santa Monica-based health company had also been sharing information about their prescriptions and illnesses with third parties such as Google and…